EVALUATION OF THE EFFICACY AND SAFETY OF METFORMIN IN THE MYOTONIC DYSTROPHY TYPE I (STEINERT’S DISEASE). PHASE III PROSPECTIVE, MULTICENTRE, RANDOMISED, DOUBLE-BLIND CONTROLLED STUDY.
RecruitingCTIS2023-507660-39-00
Assistance Publique Hopitaux De ParisMyotonic dystrophy type 1 (DM1)
Start: 2024-12-03Target: 203Updated: 2025-08-07